07:00 , May 27, 2013 |  BC Week In Review  |  Company News

Actagene Oncology Inc., Ignyta deal

Ignyta acquired Actagene, which was founded in February to develop personalized treatments for cancer. Actagene uses its Oncolome database and synthetic lethal screening, x-ray crystallography and structure-based drug design technologies to develop new chemical entities...